Publicación:
Prevalence of post‑COVID‑19 in patients with fibromyalgia: a comparative study with other inflammatory and autoimmune rheumatic diseases

dc.contributor.authorRivera, Javier
dc.contributor.authorRodríguez, Tamara
dc.contributor.authorPallarés, Marta
dc.contributor.authorCastrejón, Isabel
dc.contributor.authorGonzález, Teresa
dc.contributor.authorVallejo‑Slocker, Laura
dc.contributor.authorMolina‑Collada, Juan
dc.contributor.authorMontero, Fernando
dc.contributor.authorArias, Anna
dc.contributor.authorVallejo Pareja, Miguel Ángel
dc.contributor.authorÁlvaro‑Gracia, Jose M.
dc.contributor.authorCollado, Antonio
dc.contributor.funderAgencia Estatal de Investigación (España)
dc.date.accessioned2025-12-15T11:50:46Z
dc.date.available2025-12-15T11:50:46Z
dc.date.issued2022-05-19
dc.description.abstractObjectives: To determine the prevalence and characteristics of post-COVID-19 (PC) in fibromyalgia (FM) patients. Methods: Retrospective, multi-centric, observational study, comparing a group of FM patients (FM group) with another group of patients with other rheumatic diseases (RD group). COVID-19 diagnosis was established by positive polymerase chain reaction or antigen during acute infection or by positive antibodies thereafter. We considered PC diagnosis when symptoms remain after COVID-19. We collected the principal characteristics of COVID-19, the severity of fatigue, waking unrefreshed and cognitive impairment, and persistent symptoms. The American College of Rheumatology (ACR) criteria and the Combined Index of Severity in Fibromyalgia (ICAF) were collected in the FM group. Results: RD group (n = 56) had more pneumonia (p = 0.001) and hospital admissions (p = 0.002), but the FM group (n = 78) had a higher number of symptoms (p = 0.002). The percentage of patients with PC was similar between groups (FM group 79.5%; RD group 66.1%, p = 0.081). FM group had more PC symptoms (p = 0.001), more impairment after COVID-19 (p = 0.002) and higher severity of fatigue, waking unrefreshed and cognitive impairment (p < 0.0001). Only loss of smell was more frequent in the FM group (p = 0.005). The FM group with PC (n = 29) showed more severity of the Combined Index of Severity in Fibromyalgia (ICAF) total score and physical factor after COVID-19, while emotional, coping factors and the ACR criteria did not change. Conclusions: The prevalence of PC in FM patients is similar to RD patients. In FM patients, the presence of PC does not appear to impact the severity of FM.en
dc.description.provenanceMade available in DSpace on 2025-12-15T11:50:46Z (GMT). No. of bitstreams: 1 Vallejo_Miguel_A_Prevalence of post‑COVID‑19_MIGUEL ANGEL VALLEJO.pdf: 769287 bytes, checksum: fd56e981b462c032351fc97d222a4968 (MD5) Previous issue date: 2022-05-19en
dc.description.versionversión publicada
dc.identifier.citationRivera, J., Rodríguez, T., Pallarés, M. et al. Prevalence of post-COVID-19 in patients with fibromyalgia: a comparative study with other inflammatory and autoimmune rheumatic diseases. BMC Musculoskelet Disord 23, 471 (2022). https://doi.org/10.1186/s12891-022-05436-0
dc.identifier.doihttps://doi.org/10.1186/s12891-022-05436-0
dc.identifier.issn1471-2474
dc.identifier.urihttps://hdl.handle.net/20.500.14468/31136
dc.journal.titleBMC Musculoskeletal Disorders
dc.journal.volume23
dc.language.isoen
dc.publisherSpringer
dc.relation.centerFacultad de Psicología
dc.relation.departmentPsicología de la Personalidad, Evaluación y Tratamiento Psicológico
dc.relation.projectidinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/PSI2017–85447-R/ES/PROCEDIMIENTO BREVE DE REGULACION EMOCIONAL PARA LA FIBROMIALGIA, A TRAVES DE INTERNET
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.es
dc.subject6111 Personalidad
dc.subject.keywordsFibromyalgiaen
dc.subject.keywordsCOVID-19en
dc.subject.keywordsPost COVID-19en
dc.subject.keywordsLong COVID-19en
dc.subject.keywordsRheumatic diseasesen
dc.titlePrevalence of post‑COVID‑19 in patients with fibromyalgia: a comparative study with other inflammatory and autoimmune rheumatic diseasesen
dc.typeartículoes
dc.typejournal articleen
dspace.entity.typePublication
relation.isAuthorOfPublicationd180bc15-31cb-4283-b24b-0912910093aa
relation.isAuthorOfPublication.latestForDiscoveryd180bc15-31cb-4283-b24b-0912910093aa
Archivos
Bloque original
Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
Vallejo_Miguel_A_Prevalence of post‑COVID‑19_MIGUEL ANGEL VALLEJO.pdf
Tamaño:
751.26 KB
Formato:
Adobe Portable Document Format
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
3.62 KB
Formato:
Item-specific license agreed to upon submission
Descripción: